We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Detection of Pathogenic Microorganisms in Semen by Sequencing Sperm RNA

By LabMedica International staff writers
Posted on 11 Feb 2020
Print article
Image:  Human sperm stained for semen quality testing in the clinical laboratory (Photo courtesy of Wikimedia Commons)
Image: Human sperm stained for semen quality testing in the clinical laboratory (Photo courtesy of Wikimedia Commons)
Advanced sequencing of sperm RNA was used to detect genetic material from microorganisms that were present as contaminants in the associated semen.

The current approach for analysis of the male reproductive tract microbiome relies on identification of micoroorganisms grown from cultures. This approach is of limited value, since the majority of pathogens cannot be cultured.

Investigators at Wayne State University (Detroit, MI, USA) and colleagues at the CReATe Fertility Center (Toronto, Canada) and the University of Massachusetts Amherst (USA) conducted a study designed to assess the capacity of human sperm RNA-seq (RNA sequencing) data to gauge the diversity of the microbiome present within the semen.

For this study, the investigators collected 85 semen samples, isolated the sperm RNA, and analyzed the material using RNA sequencing technology. Microbial composition was determined by aligning sequencing reads not mapped to the human genome to the [U.S.] National Center for Biotechnology Information (NCBI) RefSeq bacterial, viral, and archaeal genomes.

Microbial composition within each sample was characterized as a function of microbial associated RNAs. Results revealed that bacteria known to be associated with the male reproductive tract were present at similar levels in all samples representing 11 genera from four phyla with one exception, an outlier. The outlier sample exhibited a dramatic increase in Streptococcus, represented by two operational taxonomic units, S. agalactiae and S. dysgalactiae. These bacteria cause neonatal infection during pregnancy and post-delivery and are linked to significant mortality rates in premature births.

"We show that non-targeted sequencing of human sperm RNA has the potential to provide a profile of micro-organisms (bacteria, viruses, archaea)," said Dr. Stephen Krawetz, professor of fetal therapy and diagnosis at Wayne State University. "This information was recovered from the data typically cast aside as part of routine nucleic acid sequencing. The enhanced sensitivity and specificity of the sequencing technology as compared to current approaches may prove useful as a diagnostic tool for microbial status as part of the routine assessment as we move toward personalized care. Given the recent increase and severity of Streptococcus (agalactiae) infection, as well as others in adults, neonates, and newborns, non-targeted human sperm RNA sequencing data may, in addition to providing fertility status, prove useful as a diagnostic for microbial status."

The RNA sequencing study was published in the January 4, 2020, online edition of the Journal of Assisted Reproduction and Genetics.

Related Links:
Wayne State University
CReATe Fertility Center
University of Massachusetts Amherst


New
Platinum Member
Flu SARS-CoV-2 Combo Test
OSOM® Flu SARS-CoV-2 Combo Test
Magnetic Bead Separation Modules
MAG and HEATMAG
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article
77 ELEKTRONIKA

Channels

Clinical Chemistry

view channel
Image: PhD student and first author Tarek Eissa has analyzed thousands of molecular fingerprints (Photo courtesy of Thorsten Naeser / MPQ / Attoworld)

Screening Tool Detects Multiple Health Conditions from Single Blood Drop

Infrared spectroscopy, a method using infrared light to study the molecular composition of substances, has been a foundational tool in chemistry for decades, functioning similarly to a molecular fingerprinting... Read more

Hematology

view channel
Image: The Truvian diagnostic platform combines clinical chemistry, immunoassay and hematology testing in a single run (Photo courtesy of Truvian Health)

Automated Benchtop System to Bring Blood Testing To Anyone, Anywhere

Almost all medical decisions are dependent upon laboratory test results, which are essential for disease prevention and the management of chronic illnesses. However, routine blood testing remains limited worldwide.... Read more

Immunology

view channel
Image: The blood test measures lymphocytes  to guide the use of multiple myeloma immunotherapy (Photo courtesy of 123RF)

Simple Blood Test Identifies Multiple Myeloma Patients Likely to Benefit from CAR-T Immunotherapy

Multiple myeloma, a type of blood cancer originating from plasma cells in the bone marrow, sees almost all patients experiencing a relapse at some stage. This means that the cancer returns even after initially... Read more

Microbiology

view channel
Image: Ultra-Rapid Antimicrobial Susceptibility Testing (uRAST) revolutionizing traditional antibiotic susceptibility testing (Photo courtesy of Seoul National University)

Ultra-Rapid Culture-Free Sepsis Test Reduces Testing Time from Days to Hours

Sepsis, a critical emergency condition, results from an overactive inflammatory response to pathogens like bacteria or fungi in the blood, leading to organ damage and the possibility of sudden death.... Read more

Pathology

view channel
Image: The AI model can distinguish different stages of DCIS from inexpensive and readily available breast tissue images (Photo courtesy of David A. Litman/Shutterstock)

AI Model Identifies Breast Tumor Stages Likely To Progress to Invasive Cancer

Ductal carcinoma in situ (DCIS) is a non-invasive type of tumor that can sometimes progress to a more lethal form of breast cancer and represents about 25% of all breast cancer cases. Between 30% and 50%... Read more

Industry

view channel
Image: Beckman Coulter will utilize the ALZpath pTau217 antibody to detect key biomarker for Alzheimer\'s disease on its DxI 9000 immunoassay analyzer (Photo courtesy of Beckman Coulter)

Beckman Coulter Licenses Alzpath's Proprietary P-tau 217 Antibody to Develop Alzheimer's Blood Test

Cognitive assessments have traditionally been the primary method for diagnosing Alzheimer’s disease, but this approach has its limitations as symptoms become apparent only after significant brain changes... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.